Tema Heart & Health ETF Rating $36.03 -0.51 (-1.40%) Closing price 03:59 PM EasternExtended Trading$35.98 -0.05 (-0.14%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Tema Heart & Health ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.80Holdings in HRTS have an aggregate rating of Moderate Buy based on 529 analyst ratings issued in the past year covering 22 companies (74.1% of the portfolio).HRTS Aggregate Price Target$36.03High Prediction$36.03Average Prediction$36.03Low Prediction$36.03Holdings in HRTS have an aggregate price target of $36.03 and a range of $36.03 to $36.03 covering 22 companies (74.1% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Heart & Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 HRTS Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings11.31%LLYEli Lilly and Company$1,153.69-1.4%Moderate Buy$1,305.25 13.1%304.8182 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision5.57%TMOThermo Fisher Scientific$665.77+1.1%Moderate Buy$624.64 -6.2%263.7904 of 5 starsTrending News5.02%UNHUnitedHealth Group$370.76-0.6%Moderate Buy$456.56 23.1%274.9635 of 5 starsTrending NewsAnalyst Revision4.37%MRKMerck & Co., Inc.$148.07-1.9%Moderate Buy$154.24 4.2%244.2903 of 5 starsTrending NewsAnalyst Upgrade4.00%RHHBYRoche$55.06-1.1%Moderate Buy$60.00 9.0%123.5007 of 5 starsTrending News3.96%JNJJohnson & Johnson$269.01-0.1%Moderate Buy$274.13 1.9%254.4215 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.63%RVMDRevolution Medicines$190.74-1.1%Moderate Buy$228.21 19.6%223.3171 of 5 starsAnalyst Forecast3.57%CYTKCytokinetics$65.81-2.6%Moderate Buy$103.37 57.1%202.698 of 5 starsInsider Trade3.26%GILDGilead Sciences$151.37-0.9%Moderate Buy$158.78 4.9%293.4901 of 5 starsPositive NewsAnalyst Revision3.18%BBIOBridgeBio Pharma$65.71-5.1%Moderate Buy$102.61 56.2%233.3628 of 5 starsInsider Trade3.01%DHRDanaher$221.80+0.3%Moderate Buy$229.32 3.4%243.1716 of 5 stars2.97%ABTAbbott Laboratories$103.62-0.1%Moderate Buy$119.50 15.3%274.8364 of 5 starsTrending NewsDividend Announcement2.94%VRTXVertex Pharmaceuticals$516.34+0.3%Moderate Buy$573.83 11.1%233.7845 of 5 starsTrending NewsAnalyst Forecast2.48%ABBVAbbVie$265.43+0.1%Moderate Buy$276.64 4.2%253.8401 of 5 starsTrending News2.28%ISRGIntuitive Surgical$398.30-0.9%Moderate Buy$508.68 27.7%314.368 of 5 starsAnalyst Downgrade2.24%MDTMedtronic$89.28-1.6%Moderate Buy$103.92 16.4%284.9642 of 5 starsTrending News2.21%BMYBristol Myers Squibb$61.14-1.8%Moderate Buy$67.06 9.7%254.7372 of 5 starsAnalyst Forecast1.95%MCKMcKesson$882.60-1.0%Moderate Buy$973.44 10.3%184.3331 of 5 starsTrending News1.80%DXCMDexCom$87.73-2.0%Moderate Buy$89.08 1.5%262.8904 of 5 stars1.47%MDGLMadrigal Pharmaceuticals$513.02-1.1%Moderate Buy$701.33 36.7%183.2775 of 5 starsAnalyst Forecast1.45%SYKStryker$273.55-0.6%Moderate Buy$374.42 36.9%234.9236 of 5 starsAnalyst ForecastGap Up1.42%EWEdwards Lifesciences$86.83-2.2%Moderate Buy$100.27 15.5%234.2586 of 5 starsPositive News This page (NASDAQ:HRTS) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts